FOURTEENTH INTERNATIONAL PATHOGENIC NEISSERIA CONFERENCE

第十四届国际致病性奈瑟菌会议

基本信息

  • 批准号:
    6837459
  • 负责人:
  • 金额:
    $ 0.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-08-01 至 2005-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The purpose of this proposal is to request support for "The Fourteenth International Pathogenic Neisseria Conference" which will be held September 5-10, 2004 at the Hyatt Regency Hotel in Milwaukee, Wisconsin. The emphasis of this Conference is the public health impact of the pathogenic Neisseria in both developed and developing countries, and how basic and applied research are contributing to the diagnosis, treatment, and prevention of diseases caused by these bacteria. This is the major international conference in the field that attracts over 500 scientists and public health officials from over 30 countries. The first conference in the series was held in 1978, in San Francisco and conferences have been held every two years since then, alternating between Europe and North America. The conferences in the past have allowed for the establishment of close interactions among scientists from different scientific backgrounds for an exchange of ideas, expertise, and new technologies. Such interdisciplinary collaborations have fostered open dialogues and it is expected that the 14th International Pathogenic Neisseria Conference will continue in this tradition. This proposal requests support for 20 students, postdoctoral fellows and young investigators to attend the conference. The Specific Aims of the meeting are: 1. To bring together investigators from universities, governments and the biologics industry who study Neisseria gonorrhoeae and Neisseria meningitidis and the diseases that these pathogens cause. 2. To assess the current studies on the molecular mechanisms by which the pathogenic Neisseria are able to invade and evade the host immune system. 3. To share new developments in neisserial genomics and to discuss studies of gene expression and further understanding of interactions of Neisseria with infected hosts. 4. To evaluate new and developing vaccines and treatment to prevent neisserial disease. 5. To disseminate important new findings concerning the pathogenic mechanisms and epidemiological surveillance of Neisseria and provide information to improve control through immunization. 6. To develop new research agenda for the study of the pathogenic Neisseria and to recommend new and future research initiatives and prioritize these.
描述(由申请人提供):该提案的目的是要求对2004年9月5日至10日在威斯康星州密尔沃基的凯悦酒店举行的“ 14号国际致病性奈瑟里亚会议”。这次会议的重点是发达国家和发展中国家的致病性奈瑟氏菌对公共卫生的影响,以及基础研究和应用研究如何促进由这些细菌引起的疾病的诊断,治疗和预防。这是该领域的主要国际会议,吸引了来自30多个国家 /地区的500多名科学家和公共卫生官员。该系列的第一次会议于1978年在旧金山举行,此后两年一次举行一次会议,在欧洲和北美之间交替。过去的会议使来自不同科学背景的科学家之间建立了密切的互动,以交换思想,专业知识和新技术。这种跨学科的合作促进了公开对话,预计第14届国际致病性奈瑟里亚会议将继续以这一传统继续进行。该提案要求支持20名学生,博士后研究员和年轻调查人员参加会议。 会议的具体目的是: 1。将研究淋病奈瑟氏菌和奈瑟氏菌的研究人员聚集在一起,以及这些病原体引起的疾病。 2。为了评估有关病原性奈瑟氏菌能够侵入和逃避宿主免疫系统的分子机制的当前研究。 3。分享奈瑟氏菌表达的新发展,并讨论奈瑟氏菌与受感染宿主的相互作用的进一步理解。 4。评估新的和开发的疫苗和治疗以预防奈瑟氏病。 5。传播有关奈瑟氏病的致病机制和流行病学监测的重要新发现,并提供信息以通过免疫来改善控制。 6。为了制定新的研究议程来研究致病性奈瑟氏菌,并推荐新的和未来的研究计划并将其优先考虑。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael A. Apicella其他文献

Dynamics of dendritic cell migration and the subsequent induction of protective immunity in the lung after repeated airway challenges by nontypeable <em>Haemophilus influenzae</em> outer membrane protein
  • DOI:
    10.1016/j.vaccine.2006.04.041
  • 发表时间:
    2006-07-26
  • 期刊:
  • 影响因子:
  • 作者:
    Shin-ichi Kurita;Jun Koyama;Shozaburo Onizuka;Kazushi Motomura;Hiroshi Watanabe;Kiwao Watanabe;Masachika Senba;Michael A. Apicella;Timothy F. Murphy;Horoyuki Yoneyama;Kouji Matsushima;Tsuyoshi Nagatake;Kazunori Oishi
  • 通讯作者:
    Kazunori Oishi

Michael A. Apicella的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael A. Apicella', 18)}}的其他基金

Effect of Quorum Sensing on N. gonorrhoeae infection of human PMN's
群体感应对人中性粒细胞淋病奈瑟菌感染的影响
  • 批准号:
    8837569
  • 财政年份:
    2014
  • 资助金额:
    $ 0.65万
  • 项目类别:
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
淋病奈瑟菌群体感应和生物膜形成中的赖氨酸乙酰化
  • 批准号:
    8705141
  • 财政年份:
    2014
  • 资助金额:
    $ 0.65万
  • 项目类别:
Effect of Quorum Sensing on N. gonorrhoeae infection of human PMN's
群体感应对人中性粒细胞淋病奈瑟菌感染的影响
  • 批准号:
    8621355
  • 财政年份:
    2014
  • 资助金额:
    $ 0.65万
  • 项目类别:
Studies of the capsular-like antigen of F. tularensis
土拉弗拉菌荚膜样抗原的研究
  • 批准号:
    8305635
  • 财政年份:
    2011
  • 资助金额:
    $ 0.65万
  • 项目类别:
Etiology of Cystic Fibrosis-Related Diabetes in a CFTR-knockout Ferret
CFTR 敲除雪貂中囊性纤维化相关糖尿病的病因学
  • 批准号:
    8079159
  • 财政年份:
    2011
  • 资助金额:
    $ 0.65万
  • 项目类别:
Studies of the capsular-like antigen of F. tularensis
土拉弗拉菌荚膜样抗原的研究
  • 批准号:
    7920674
  • 财政年份:
    2010
  • 资助金额:
    $ 0.65万
  • 项目类别:
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: LUNG
购买 JEOL JSM-7401F FESEM 的资金:肺
  • 批准号:
    7335218
  • 财政年份:
    2006
  • 资助金额:
    $ 0.65万
  • 项目类别:
Funds to acquire a JEOL JSM-7401F FESEM
购买 JEOL JSM-7401F FESEM 的资金
  • 批准号:
    7041487
  • 财政年份:
    2006
  • 资助金额:
    $ 0.65万
  • 项目类别:
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: CYSTIC FIBROSIS
获得资金购买 JEOL JSM-7401F FESEM:囊性纤维化
  • 批准号:
    7335219
  • 财政年份:
    2006
  • 资助金额:
    $ 0.65万
  • 项目类别:
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: INFECTIOUS DISEASE
获得 JEOL JSM-7401F FESEM 的资金:传染病
  • 批准号:
    7335217
  • 财政年份:
    2006
  • 资助金额:
    $ 0.65万
  • 项目类别:

相似海外基金

Snodgrassella alvi as an attenuated live vaccine against Neisseria gonorrhoeae
Snodgrassella alvi 作为针对淋病奈瑟菌的减毒活疫苗
  • 批准号:
    10263891
  • 财政年份:
    2020
  • 资助金额:
    $ 0.65万
  • 项目类别:
NEISSERIAL PORINS AND ANTIGEN PRESENTING CELL
奈瑟氏球菌孔蛋白和抗原呈递细胞
  • 批准号:
    2005498
  • 财政年份:
    1997
  • 资助金额:
    $ 0.65万
  • 项目类别:
NEISSERIAL PORINS AND ANTIGEN PRESENTING CELL
奈瑟氏球菌孔蛋白和抗原呈递细胞
  • 批准号:
    2723933
  • 财政年份:
    1997
  • 资助金额:
    $ 0.65万
  • 项目类别:
NEISSERIAL PORINS AND ANTIGEN PRESENTING CELL
奈瑟氏球菌孔蛋白和抗原呈递细胞
  • 批准号:
    2672938
  • 财政年份:
    1997
  • 资助金额:
    $ 0.65万
  • 项目类别:
Neisserial Porins and Antigen Presenting Cells
奈瑟氏球菌孔蛋白和抗原呈递细胞
  • 批准号:
    6737448
  • 财政年份:
    1997
  • 资助金额:
    $ 0.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了